Update on trials of Celator Pharma's cancer candidate; Can turmeric treat Alzheimer's?;

> Celator Pharmaceuticals' stock rose on positive clinical trial results of its Phase II candidate for acute myeloid leukemia, which uses its CombiPlex delivery platform. Release

> Vanderbilt University is studying curcumin, found in the spice turmeric, as a treatment for Alzheimer's disease. "Curcumin has demonstrated ability to enter the brain, bind and destroy the beta-amyloid plaques present in Alzheimer's with reduced toxicity," said biomedical engineering professor Wellington Pham. Story

> University of Florida spinoff Prometheon Pharma is promoting its needle-free transdermal patch to external partners. The patch contains a formulation that melts into a gel upon contact with the skin, and can deliver drugs at a constant and consistent rate, according to the company. Release

> BioLight Life Sciences announced that it has invested in a new ophthalmic company which has the rights to novel drug delivery platform developed by Hebrew University in Israel. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.